Business
A Gene Therapy for an Inherited Blindness Just Passed Its Pivotal Test
Beacon’s one-time eye gene therapy improved low-light vision in men with X-linked retinitis pigmentosa — the first pivotal trial in this blinding disease to hit its main goal.